Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
US6613785B2 · kind B2 · utility
13Cited by
1References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 21, 2003 |
| Grant date | Sep 2, 2003 |
| Priority date | — |
| Expiry date | Jan 21, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/427
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for reducing post-ischaemic injury of the heart and/or improving the functional recovery of the heart following myocardial ischaemia which method comprises administration of an effective, non-toxic amount of a glucose uptake enhancer to a human or non-human mammal in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.